Usability and Acceptability Study of the P-STEP Mobile Application
| 适应症 | Asthma, Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Coronary Heart Disease |
|---|---|
| 分期 | 不适用 |
| 申办方 | University of Leicester |
| 状态 | 已完成 |
| 受试者人数 | 178 人 |
| 干预（药物） | P-STEP Mobile Application |
| 开始日期 | 2023年8月23日 |
| 完成日期 | 2024年2月1日 |
| 结果公布日 | 2026年5月1日 |
摘要
Assess the usability and acceptance of the P-STEP app, through allowing participants with specific chronic conditions to pilot the app for 12-weeks.
System Usability Scale
| 6-weeks | 57.92 ± 20.12 score on a scale |
|---|---|
| 12-week | 61.68 ± 22.09 score on a scale |
在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文
同一适应症的其他试验
- Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and — University of Tennessee Graduate School of Medicine
- Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster — Chiesi Farmaceutici S.p.A.
- Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®T — Chiesi Farmaceutici S.p.A.
- Tiotropium/Salmeterol Inhalation Powder in COPD — Boehringer Ingelheim
- Risk Factors, Costs, and Impacts of ED Boarding — University of Maryland, Baltimore
- Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructiv — United Therapeutics